Proposed Data Collections Submitted for Public Comment and Recommendations, 13653-13654 [2014-05231]
Download as PDF
<![CDATA[
emcdonald on DSK67QTVN1PROD with NOTICES
Federal Register / Vol. 79, No. 47 / Tuesday, March 11, 2014 / Notices
to disclose that the experts were ADT’s
paid spokespersons.
The proposed order includes
injunctive relief to address these alleged
violations and requires ADT to follow
certain monitoring and compliance
procedures related to its use of paid
spokespersons.
Part I of the proposed order prohibits
ADT, in connection with the advertising
of any security or monitoring product or
service, from misrepresenting that a
discussion or demonstration of such
product or service is an independent
review provided by an impartial expert.
Part II of the proposed order requires
ADT, in connection with the advertising
of any security or monitoring product by
means of an endorsement, to disclose
clearly and prominently a material
connection, if one exists, between the
endorser and ADT.
Part III of the proposed order requires
ADT to take all reasonable steps to
remove, within seven days of service of
the order, any demonstration, review, or
endorsement, by an endorser with a
material connection to ADT, that does
not comply with Parts I and II of the
order.
Part IV of the proposed order sets out
certain monitoring and compliance
obligations that ADT must meet with
respect to any endorser with a material
connection to ADT, including: obtaining
signed acknowledgements from such
endorsers that they will disclose their
connection to ADT; monitoring the
endorsers’ media appearances and
online reviews; terminating endorsers
who fail to disclose their connection to
ADT; and maintaining records of its
monitoring efforts.
Parts V through VIII of the proposed
order require ADT to: Keep copies of
relevant consumer complaints and
inquiries and documents demonstrating
order compliance; provide copies of the
order to officers, employees, and others
with responsibilities with respect to the
subject matter of the order; notify the
Commission of changes in corporate
structure that might affect compliance
obligations under the order; and file
compliance reports with the
Commission.
Part IX provides that the order will
terminate after twenty (20) years, with
certain exceptions.
The purpose of this analysis is to
facilitate public comment on the
proposed order, and it is not intended
to constitute an official interpretation of
the complaint or proposed order, or to
modify the proposed order’s terms in
any way.
VerDate Mar<15>2010
17:22 Mar 10, 2014
Jkt 232001
By direction of the Commission.
Donald S. Clark,
Secretary.
[FR Doc. 2014–05262 Filed 3–10–14; 8:45 am]
BILLING CODE 6750–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
HHS Approval of Entities That Certify
Medical Review Officers (MRO)
Substance Abuse and Mental
Health Services Administration
(SAMHSA), Department of Health and
Human Services.
ACTION: Notice.
AGENCY:
The current version of the
Department of Health and Human
Services (HHS) Mandatory Guidelines
for Federal Workplace Drug Testing
Programs (Mandatory Guidelines),
effective on October 1, 2010, addresses
the role and qualifications of Medical
Review Officers (MROs) and HHS
approval of entities that certify MROs.
Subpart M-Medical Review Officer
(MRO), Section 13.1(b), ‘‘Who may serve
as an MRO?’’ states as follows:
‘‘Nationally recognized entities that
certify MROs or subspecialty boards for
physicians performing a review of
Federal employee drug testing results
that seek approval by the Secretary must
submit their qualifications and a sample
examination. Based on an annual
objective review of the qualifications
and content of the examination, the
Secretary shall publish a list in the
Federal Register of those entities and
boards that have been approved.’’
HHS has completed its review of
entities that train and certify MROs, in
accordance with requests submitted by
such entities to HHS.
(1) The HHS Secretary approves the
following MRO certifying entities that
offer both MRO training and
certification through examination:
American Association of Medical
Review Officers (AAMRO), P.O. Box
12873, Research Triangle Park, NC
27709, Phone: (800) 489–1839, Fax:
(919) 490–1010, Email: cferrell@
aamro.com, Web site: https://
www.aamro.com/.
Medical Review Officer Certification
Council (MROCC), 836 Arlington
Heights Road, #327, Elk Grove
Village, IL 60007, Phone: (847) 631–
0599, Fax: (847) 483–1282, Email:
mrocc@mrocc.org, Web site: https://
www.mrocc.org/.
(2) The HHS Secretary lists the
following entities that offer MRO
training as a prerequisite for MRO
certification:
SUMMARY:
PO 00000
Frm 00044
Fmt 4703
Sfmt 4703
13653
American College of Occupational and
Environmental Medicine (ACOEM),
25 Northwest Point Boulevard, Suite
700, Elk Grove Village, IL 60007–
1030, Phone: (847) 818–1800, Fax:
(847) 818–9266, Contact Form:
https://www.acoem.org/
contactacoem.aspx, Web site: https://
www.acoem.org/.
American Society of Addiction
Medicine (ASAM), 4601 N. Park
Avenue, Upper Arcade #101, Chevy
Chase, MD 20815, Phone: (301) 656–
3920, Fax: (301) 656–3815, Email:
email@asam.org, Web site: https://
www.asam.org/.
DATES: HHS approval is effective March
11, 2014.
FOR FURTHER INFORMATION CONTACT:
Jennifer Fan, Pharm.D., J.D., Division of
Workplace Programs (DWP), Center for
Substance Abuse Prevention (CSAP),
Substance Abuse and Mental Health
Services Administration (SAMHSA), 1
Choke Cherry Road, Room 7–1038,
Rockville, MD 20857; Telephone: (240)
276–1759; Email: jennifer.fan@
samhsa.hhs.gov
Dated: February 27, 2014.
Kathleen Sebelius,
Secretary.
[FR Doc. 2014–05283 Filed 3–10–14; 8:45 am]
BILLING CODE 4160–20–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–14–0896]
Proposed Data Collections Submitted
for Public Comment and
Recommendations
In compliance with the requirement
of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for
opportunity for public comment on
proposed data collection projects, the
Centers for Disease Control and
Prevention (CDC) will publish periodic
summaries of proposed projects. To
request more information on the
proposed projects or to obtain a copy of
the data collection plans and
instruments, call 404–639–7570 or send
comments to LeRoy Richardson, 1600
Clifton Road, MS–D74, Atlanta, GA
30333 or send an email to omb@cdc.gov.
Comments are invited on: (a) Whether
the proposed collection of information
is necessary for the proper performance
of the functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
E:\FR\FM\11MRN1.SGM
11MRN1
13654
Federal Register / Vol. 79, No. 47 / Tuesday, March 11, 2014 / Notices
proposed collection of information; (c)
ways to enhance the quality, utility, and
clarity of the information to be
collected; and (d) ways to minimize the
burden of the collection of information
on respondents, including through the
use of automated collection techniques
or other forms of information
technology. Written comments should
be received within 60 days of this
notice.
Proposed Project
Community-based Organization (CBO)
Monitoring and Evaluation of WILLOW
(CMEP–WILLOW) (0920–0896 Exp. 8/
31/2014)—Revision—National Center
for HIV/AIDS, Viral Hepatitis, STD, and
TB Prevention, Centers for Disease
Control and Prevention (CDC).
Background and Brief Description
CDC began formally partnering with
CBOs in the late 1980s to expand the
reach of HIV prevention efforts. CBOs
were, and continue to be, recognized as
important partners in HIV prevention
because of their history and credibility
with target populations and their access
to groups that may not be easily
reached. Over time, CDC’s program for
HIV prevention by CBOs has grown in
size, scope, and complexity to respond
to changes in the epidemic, including
the diffusion and implementation of
Effective Behavioral Interventions (EBIs)
for HIV prevention.
CDC’s EBIs have been shown to be
effective under controlled research
environments, but there is limited data
on intervention implementation and
client outcomes in real-world settings
(as implemented by CDC-funded CBOs).
The purpose of CMEP–WILLOW is to (a)
assess the fidelity of the implementation
of the selected intervention at the CBO;
and (b) improve the performance of
CDC-funded CBOs delivering the
WILLOW intervention by monitoring
changes in clients’ self-reported
attitudes and beliefs regarding HIV and
HIV transmission risk behaviors after
participating in WILLOW.
CDC funded four (4) CBOs to
participate in CMEP–WILLOW for five
(5) years (September 2010-August 2015).
From September 1, 2012 through
January 31, 2014, baseline surveys were
conducted with 825 participants; 90-day
follow up surveys were completed with
566 participants, and 180-day follow up
surveys were completed with 463
participants.
CDC is requesting additional time to
complete follow up surveys at 90- and
180-days for participants completing the
intervention on or before 8/31/2014.
Following their participation in the
WILLOW intervention, participants will
complete an 18-minute, self-
administered, computer-based interview
at two follow-up time points (90- and
180-days following the WILLOW
intervention) to assess their HIV-related
attitudes and behavioral risks. CBOs
will be expected to retain 80% of these
participants at both follow-up
interviews.
Throughout the project, funded CBOs
will be responsible for managing the
daily procedures of CMEP–WILLOW to
ensure that all required activities are
performed, all deadlines are met, and
quality assurance plans, policies and
procedures are upheld. CBOs will be
responsible for participating in all CDCsponsored grantee meetings related to
CMEP–WILLOW.
Findings from this project will be
primarily used by the participating
CBOs. The CBOs may use the findings
to (a) better understand if the outcomes
are different across demographic and
behavioral risk groups as well as agency
and program model characteristics; (b)
improve the future implementation,
management, and quality of WILLOW;
and (c) guide their overall HIV
prevention programming for women
living with HIV. CDC and other
organizations interested in behavioral
outcome monitoring of WILLOW or
similar HIV prevention interventions
can also benefit from lessons learned
through this project.
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
responses
per
respondent
Number of
respondents
Average
burden
response
(in hours)
Total
burden
(in hours)
Type of respondents
Form name
General population ...................................................................
90-day Follow-up
Survey.
90-day SDN
Submission.
180-day
Follow-up
Survey.
180-day
SDN
Submission.
320
1
18/60
96
4
12
5/60
4
320
1
18/60
96
4
12
5/60
4
...................
........................
........................
........................
200
CMEP–WILLOW grantees .......................................................
General population ...................................................................
CMEP–WILLOW grantees .......................................................
emcdonald on DSK67QTVN1PROD with NOTICES
Total ..................................................................................
LeRoy Richardson,
Chief, Information Collection Review Office,
Office of Scientific Integrity, Office of the
Associate Director for Science, Office of the
Director, Centers for Disease Control and
Prevention.
[FR Doc. 2014–05231 Filed 3–10–14; 8:45 am]
BILLING CODE 4163–18–P
VerDate Mar<15>2010
17:22 Mar 10, 2014
Jkt 232001
PO 00000
Frm 00045
Fmt 4703
Sfmt 9990
E:\FR\FM\11MRN1.SGM
11MRN1
]]>Agencies
[Federal Register Volume 79, Number 47 (Tuesday, March 11, 2014)]
[Notices]
[Pages 13653-13654]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-05231]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60Day-14-0896]
Proposed Data Collections Submitted for Public Comment and
Recommendations
In compliance with the requirement of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for opportunity for public comment on
proposed data collection projects, the Centers for Disease Control and
Prevention (CDC) will publish periodic summaries of proposed projects.
To request more information on the proposed projects or to obtain a
copy of the data collection plans and instruments, call 404-639-7570 or
send comments to LeRoy Richardson, 1600 Clifton Road, MS-D74, Atlanta,
GA 30333 or send an email to omb@cdc.gov.
Comments are invited on: (a) Whether the proposed collection of
information is necessary for the proper performance of the functions of
the agency, including whether the information shall have practical
utility; (b) the accuracy of the agency's estimate of the burden of the
[[Page 13654]]
proposed collection of information; (c) ways to enhance the quality,
utility, and clarity of the information to be collected; and (d) ways
to minimize the burden of the collection of information on respondents,
including through the use of automated collection techniques or other
forms of information technology. Written comments should be received
within 60 days of this notice.
Proposed Project
Community-based Organization (CBO) Monitoring and Evaluation of
WILLOW (CMEP-WILLOW) (0920-0896 Exp. 8/31/2014)--Revision--National
Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers
for Disease Control and Prevention (CDC).
Background and Brief Description
CDC began formally partnering with CBOs in the late 1980s to expand
the reach of HIV prevention efforts. CBOs were, and continue to be,
recognized as important partners in HIV prevention because of their
history and credibility with target populations and their access to
groups that may not be easily reached. Over time, CDC's program for HIV
prevention by CBOs has grown in size, scope, and complexity to respond
to changes in the epidemic, including the diffusion and implementation
of Effective Behavioral Interventions (EBIs) for HIV prevention.
CDC's EBIs have been shown to be effective under controlled
research environments, but there is limited data on intervention
implementation and client outcomes in real-world settings (as
implemented by CDC-funded CBOs). The purpose of CMEP-WILLOW is to (a)
assess the fidelity of the implementation of the selected intervention
at the CBO; and (b) improve the performance of CDC-funded CBOs
delivering the WILLOW intervention by monitoring changes in clients'
self-reported attitudes and beliefs regarding HIV and HIV transmission
risk behaviors after participating in WILLOW.
CDC funded four (4) CBOs to participate in CMEP-WILLOW for five (5)
years (September 2010-August 2015). From September 1, 2012 through
January 31, 2014, baseline surveys were conducted with 825
participants; 90-day follow up surveys were completed with 566
participants, and 180-day follow up surveys were completed with 463
participants.
CDC is requesting additional time to complete follow up surveys at
90- and 180-days for participants completing the intervention on or
before 8/31/2014. Following their participation in the WILLOW
intervention, participants will complete an 18-minute, self-
administered, computer-based interview at two follow-up time points
(90- and 180-days following the WILLOW intervention) to assess their
HIV-related attitudes and behavioral risks. CBOs will be expected to
retain 80% of these participants at both follow-up interviews.
Throughout the project, funded CBOs will be responsible for
managing the daily procedures of CMEP-WILLOW to ensure that all
required activities are performed, all deadlines are met, and quality
assurance plans, policies and procedures are upheld. CBOs will be
responsible for participating in all CDC-sponsored grantee meetings
related to CMEP-WILLOW.
Findings from this project will be primarily used by the
participating CBOs. The CBOs may use the findings to (a) better
understand if the outcomes are different across demographic and
behavioral risk groups as well as agency and program model
characteristics; (b) improve the future implementation, management, and
quality of WILLOW; and (c) guide their overall HIV prevention
programming for women living with HIV. CDC and other organizations
interested in behavioral outcome monitoring of WILLOW or similar HIV
prevention interventions can also benefit from lessons learned through
this project.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Average
Number of Number of burden Total burden
Type of respondents Form name respondents responses per response (in (in hours)
respondent hours)
----------------------------------------------------------------------------------------------------------------
General population............ 90-day Follow-up 320 1 18/60 96
Survey.
CMEP-WILLOW grantees.......... 90-day SDN 4 12 5/60 4
Submission.
General population............ 180-day Follow- 320 1 18/60 96
up Survey.
CMEP-WILLOW grantees.......... 180-day SDN 4 12 5/60 4
Submission.
---------------------------------------------------------------------------------
Total..................... ................ .............. .............. .............. 200
----------------------------------------------------------------------------------------------------------------
LeRoy Richardson,
Chief, Information Collection Review Office, Office of Scientific
Integrity, Office of the Associate Director for Science, Office of the
Director, Centers for Disease Control and Prevention.
[FR Doc. 2014-05231 Filed 3-10-14; 8:45 am]
BILLING CODE 4163-18-P
